Finance

Lists
1789:TPE
ScinoPharm Taiwan Ltd
18,75 NT$
0,00%
(0,00) 1D
18 қар., 13:30:32 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1789...
Mkt. cap
14,83 млрд
Avg. vol.
661,72 м.
Volume
0,00
Dividend
1,55%
Quarterly dividend
0,07 NT$
Ex-dividend date
2026 ж. 02 шіл.
P/E ratio
892,43
52-wk high
29,10 NT$
52-wk low
16,70 NT$
EPS
0,02 NT$
Shares outstanding
790,74 млн
No. of employees
1 мың
Mkt. cap
14,83 млрд
Avg. vol.
661,72 м.
Volume
0,00
Dividend
1,55%
Quarterly dividend
0,07 NT$
Ex-dividend date
2026 ж. 02 шіл.
P/E ratio
892,43
52-wk high
29,10 NT$
52-wk low
16,70 NT$
EPS
0,02 NT$
Shares outstanding
790,74 млн
No. of employees
1 мың
News stories
From web sources and news partners
About ScinoPharm Taiwan Ltd
CEO-
Employees1,01 мың
Founded1997 ж. 11 қар.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
1,01 млрд
659,71 млн
678,50 млн
694,09 млн
Cost of goods sold
674,97 млн
438,17 млн
543,87 млн
546,02 млн
Cost of revenue
674,97 млн
438,17 млн
543,87 млн
546,02 млн
Research and development expenses
195,17 млн
85,54 млн
86,45 млн
93,79 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
128,12 млн
112,89 млн
113,74 млн
116,98 млн
Operating expense
325,04 млн
213,05 млн
200,04 млн
210,71 млн
Total operating expenses
1,00 млрд
651,22 млн
743,91 млн
756,73 млн
Operating income
8,03 млн
8,49 млн
-65,41 млн
-62,64 млн
Other non operating income
19,92 млн
-7,76 млн
3,85 млн
34,83 млн
EBT including unusual items
23,96 млн
19,32 млн
-53,50 млн
-16,93 млн
EBT excluding unusual items
21,96 млн
19,35 млн
-53,42 млн
-16,93 млн
Income tax expense
-17,32 млн
2,80 млн
-17,98 млн
-11,35 млн
Effective tax rate
-72,27%
14,47%
33,60%
67,07%
Other operating expenses
-
-
-
-
Net income
41,28 млн
16,53 млн
-35,53 млн
-5,57 млн
Net profit margin
4,10%
2,51%
-5,24%
-0,80%
Earnings per share
0,05
-
-
-
Interest and investment income
-
13,03 млн
14,10 млн
14,14 млн
Interest expense
-16,12 млн
-2,97 млн
-3,06 млн
-3,26 млн
Net interest expenses
-16,12 млн
10,06 млн
11,05 млн
10,88 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
134,08 млн
133,63 млн
55,46 млн
74,68 млн
Gain or loss from assets sale
188,00 м.
21,00 мың
88,00 мың
61,00 мың
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары